Silo Pharma, Inc. announced encouraging preliminary results from an ongoing study of its SP-26 ketamine extended-release rods, which are being evaluated for safety and pharmacokinetics after being ...

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) on Tuesday announced the primary analysis of its clinical trial evaluating Berubicin for recurrent or progressive Glioblastoma Multiforme (GBM), an aggressive ...

The Food and Drug Administration on Tuesday posted a warning about generic forms of a popular hair-loss medication often sold by major telehealth companies including Hims, Keeps and Ro, citing reports ...

Image above: Old ads provide side effects info against slice-of-life vignettes, a distracting no-no according to new rules. Fox News used to call itself “fair and balanced,” whether or not the network ...

Like all companies, pharmaceutical companies are required to ensure that their products are safe for use as intended. However, when pharmaceutical companies fall short of meeting this legal duty, the ...

Roche’s stock fell after new data from an early-stage clinical trial of its closely watched oral weight-loss drug candidate prompted analysts to question the company’s potential to quickly enter a ...